Drugs And Devices Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
About Drugs And Devices Pharma
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Samihuddin Kazi, Faizan Shaikh, and Wasim Noorani serve as directors at the Company.
- CIN/LLPIN
U24304GJ2019PTC111024
- Company No.
111024
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Drugs And Devices Pharma Private Limited offer?
Drugs And Devices Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Vitamin Tablets & Capsules, Sexual Wellness Products, Erectile Dysfunction Medicine, Thermometers & Flowmeters, Industrial and Medical Infrared Thermometer, Face Mask & Medical PPE Kits, Face Mask, Hand Sanitizers & Personal Hygiene.
Who are the key members and board of directors at Drugs And Devices Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samihuddin Kazi  | Director | 26-Nov-2019 | Current |
| Faizan Shaikh | Director | 26-Nov-2019 | Current |
| Wasim Noorani | Director | 27-Feb-2024 | Current |
Financial Performance of Drugs And Devices Pharma.
Drugs And Devices Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Drugs And Devices Pharma?
Unlock access to Drugs And Devices Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Drugs And Devices Pharma?
Unlock and access historical data on people associated with Drugs And Devices Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drugs And Devices Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drugs And Devices Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
